iBio, Inc.IBIONYSE
Loading
EPS Growth Under PressureDecelerating
Percentile Rank79
5Y CAGR+15.6%
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

5Y CAGR
+15.6%/yr
Long-term compound
Percentile
P79
Within normal range
vs 5Y Ago
2.1x
Strong expansion
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
202573.08%
202493.88%
202396.32%
2022-4716.71%
202180.31%
202035.41%
201938.75%
20183.75%
2017-33.33%
2016-33.33%